Finnerty CC, Jeschke MG, Branski LK, Barret JP, Dziewulski P, Herndon DN. Hypertrophic scarring: the best unmet problem after burn damage. Lancet. 2016;388:1427–36.
Zhou Q, Gong J, Bi J, Yang X, Zhang L, Lu C et al. KGF-2 regulates STAP-2-Mediated Sign Transducer and activator of transcription 3 signaling and reduces pores and skin scar formation. J Make investments Dermatol. 2022; 142:2003-13.e5.
He J, Fang B, Shan S, Xie Y, Wang C, Zhang Y, et al. Mechanical stretch promotes hypertrophic scar formation via mechanically activated cation channel Piezo1. Cell Dying Dis. 2021;12:226.
Hinz B. Formation and performance of the myofibroblast throughout tissue restore. J Make investments Dermatol. 2007;127:526–37.
Garrison G, Huang SK, Okunishi Ok, Scott JP, Kumar Penke LR, Scruggs AM, et al. Reversal of myofibroblast differentiation by prostaglandin E(2). Am J Respir Cell Mol Biol. 2013;48:550–8.
Desmoulière A, Chaponnier C, Gabbiani G. Tissue restore, contraction, and the myofibroblast. Wound Restore Regen. 2005;13:7–12.
Cohen JN, Gouirand V, Macon CE, Lowe MM, Boothby IC, Moreau JM, et al. Regulatory T cells in pores and skin mediate immune privilege of the hair follicle stem cell area of interest. Sci Immunol. 2024;9:eadh0152.
Yu H, Feng H, Zeng H, Wu Y, Zhang Q, Yu J, et al. Exosomes: the rising mechanisms and potential scientific purposes in dermatology. Int J Biol Sci. 2024;20:1778–95.
Jackson CJ, Tønseth KA, Utheim TP. Cultured epidermal stem cells in regenerative medication. Stem Cell Res Ther. 2017;8:155.
Xu H, Yang H, Wang Z, Tang Q, Cao X, Chen C, et al. Epidermal stem cell derived exosomes alleviate extreme Autophagy Induced endothelial cell apoptosis by delivering miR200b-3p to Diabetic wounds. J Make investments Dermatol. 2024;144:1134–e472.
Wiklander OPB, Brennan M, Lötvall J, Breakefield XO, El Andaloussi S. Advances in therapeutic purposes of extracellular vesicles. Sci Transl Med. 2019; 11.
Nooshabadi VT, Mardpour S, Yousefi-Ahmadipour A, Allahverdi A, Izadpanah M, Daneshimehr F, et al. The extracellular vesicles-derived from mesenchymal stromal cells: a brand new therapeutic choice in regenerative medication. J Cell Biochem. 2018;119:8048–73.
Liao L, Shi B, Chang H, Su X, Zhang L, Bi C, et al. Heparin improves BMSC cell remedy: anticoagulant therapy by heparin improves the security and therapeutic impact of bone marrow-derived mesenchymal stem cell cytotherapy. Theranostics. 2017;7:106–16.
Son D, Harijan A. Overview of surgical scar prevention and administration. J Korean Med Sci. 2014;29:751–7.
Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and therapy. Dermatol Surg. 2017;43(Suppl 1):S3–18.
Kose O, Botsali A, Caliskan E. Function of exosomes in pores and skin illnesses. J Cosmet Dermatol. 2022;21:3219–25.
Yang H, Xu H, Wang Z, Li X, Wang P, Cao X, et al. Evaluation of miR-203a-3p/SOCS3-mediated induction of M2 macrophage polarization to advertise diabetic wound therapeutic based mostly on epidermal stem cell-derived exosomes. Diabetes Res Clin Pract. 2023;197:110573.
Wang P, Theocharidis G, Vlachos IS, Kounas Ok, Lobao A, Shu B, et al. Exosomes derived from epidermal stem cells enhance Diabetic Wound Therapeutic. J Make investments Dermatol. 2022;142:2508–e1713.
Lee HJ, Jang YJ. Current understandings of Biology, Prophylaxis and Therapy methods for hypertrophic scars and keloids. Int J Mol Sci. 2018; 19.
Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141:1202–7.
Zhao T, Solar F, Liu J, Ding T, She J, Mao F, et al. Rising position of mesenchymal stem cell-derived exosomes in Regenerative Medication. Curr Stem Cell Res Ther. 2019;14:482–94.
Cui HS, Kim DH, Joo SY, Cho YS, Kim JB, Web optimization CH. Exosomes derived from human hypertrophic scar fibroblasts induces smad and TAK1 signaling in regular dermal fibroblasts. Arch Biochem Biophys. 2022;722:109215.
Chen J, Zhou R, Liang Y, Fu X, Wang D, Wang C. Blockade of lncRNA-ASLNCS5088-enriched exosome era in M2 macrophages by GW4869 dampens the impact of M2 macrophages on orchestrating fibroblast activation. Faseb j. 2019;33:12200–12.
Xu C, Zhang H, Yang C, Wang Y, Wang Ok, Wang R, et al. miR-125b-5p delivered by adipose-derived stem cell exosomes alleviates hypertrophic scarring by suppressing Smad2. Burns Trauma. 2024;12:tkad064.
Li Y, Zhang J, Shi J, Liu Ok, Wang X, Jia Y, et al. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis. Stem Cell Res Ther. 2021;12:221.
Liu SY, Wu JJ, Chen ZH, Zou ML, Teng YY, Zhang KW, et al. The m(6)a RNA modification modulates Gene expression and fibrosis-related pathways in hypertrophic scar. Entrance Cell Dev Biol. 2021;9:748703.
Shim J, Oh SJ, Yeo E, Park JH, Bae JH, Kim SH, et al. Built-in Evaluation of Single-Cell and spatial transcriptomics in Keloids: highlights on fibrovascular interactions in Keloid Pathogenesis. J Make investments Dermatol. 2022;142:2128–e3911.
Deng CC, Hu YF, Zhu DH, Cheng Q, Gu JJ, Feng QL, et al. Single-cell RNA-seq reveals fibroblast heterogeneity and elevated mesenchymal fibroblasts in human fibrotic pores and skin illnesses. Nat Commun. 2021;12:3709.
Zhou C, Zhang B, Yang Y, Jiang Q, Li T, Gong J, et al. Stem cell-derived exosomes: rising therapeutic alternatives for wound therapeutic. Stem Cell Res Ther. 2023;14:107.
Zhao J, Yang S, Xu Y, Qin S, Bie F, Chen L, et al. Mechanical pressure-induced dedifferentiation of myofibroblasts inhibits scarring by way of SMYD3/ITGBL1 signaling. Dev Cell. 2023;58:1139–e526.
Zhou S, Wang W, Zhou S, Zhang G, He J, Li Q. A Novel Mannequin for Cutaneous Wound Therapeutic and Scarring within the rat. Plast Reconstr Surg. 2019;143:468–77.
Santos A, Lagares D. Matrix stiffness: the conductor of Organ Fibrosis. Curr Rheumatol Rep. 2018;20:2.
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349–63.
Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one operate, a number of origins. Am J Pathol. 2007;170:1807–16.
Younesi FS, Miller AE, Barker TH, Rossi FMV, Hinz B. Fibroblast and myofibroblast activation in regular tissue restore and fibrosis. Nat Rev Mol Cell Biol. 2024;25:617–38.
Zhao S, Liu H, Wang H, He X, Tang J, Qi S, et al. Inhibition of phosphatidylinositol 3-kinase catalytic subunit alpha by miR-203a-3p reduces hypertrophic scar formation by way of phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway. Burns Trauma. 2024;12:tkad048.
Steiner JE, Cottrell CE, Streicher JL, Jensen JN, King DM, Burrows PE, et al. Scarring in sufferers with PIK3CA-Associated overgrowth syndromes. JAMA Dermatol. 2018;154:452–5.
Liu M, Yang P, Fu D, Gao T, Deng X, Shao M, et al. Allicin protects in opposition to myocardial I/R by accelerating angiogenesis by way of the miR-19a-3p/PI3K/AKT axis. Growing old. 2021;13:22843–55.
Hu ZC, Chen D, Guo D, Liang YY, Zhang J, Zhu JY, et al. Randomized scientific trial of autologous pores and skin cell suspension mixed with pores and skin grafting for power wounds. Br J Surg. 2015;102:e117–23.
Blanpain C, Fuchs E. Epidermal stem cells of the pores and skin. Annu Rev Cell Dev Biol. 2006;22:339–73.
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.
Yang RH, Qi SH, Shu B, Ruan SB, Lin ZP, Lin Y et al. Epidermal stem cells (ESCs) speed up diabetic wound therapeutic by way of the notch signalling pathway. Biosci Rep. 2016; 36.
Yamanaka S. Pluripotent stem cell-based Cell Remedy-Promise and challenges. Cell Stem Cell. 2020;27:523–31.
Mazini L, Rochette L, Admou B, Amal S, Malka G. Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in Wound Therapeutic. Int J Mol Sci. 2020; 21.
Zhang H, Peng L, Wang Y, Zhao W, Lau WB, Wang Y, et al. Extracellular vesicle-derived miR-144 as a novel mechanism for power intermittent hypoxia-induced endothelial dysfunction. Theranostics. 2022;12:4237–49.
Li Z, Track Y, He T, Wen R, Li Y, Chen T, et al. M2 microglial small extracellular vesicles cut back glial scar formation by way of the miR-124/STAT3 pathway after ischemic stroke in mice. Theranostics. 2021;11:1232–48.
Mori MA, Ludwig RG, Garcia-Martin R, Brandão BB, Kahn CR. Extracellular miRNAs: from biomarkers to mediators of physiology and illness. Cell Metab. 2019;30:656–73.
Pefanis E, Wang J, Rothschild G, Lim J, Kazadi D, Solar J, et al. RNA exosome-regulated lengthy non-coding RNA transcription controls super-enhancer exercise. Cell. 2015;161:774–89.
Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA. The fusion of two worlds: non-coding RNAs and extracellular vesicles–diagnostic and therapeutic implications (assessment). Int J Oncol. 2015;46:17–27.
Hu Y, Rao SS, Wang ZX, Cao J, Tan YJ, Luo J, et al. Exosomes from human umbilical wire blood speed up cutaneous wound therapeutic via mir-21-3p-mediated promotion of angiogenesis and fibroblast operate. Theranostics. 2018;8:169–84.
Huang R, He L, Xia Y, Xu H, Liu C, Xie H, et al. A delicate Aptasensor based mostly on a Hemin/G-Quadruplex-Assisted Sign Amplification Technique for Electrochemical Detection of Gastric Most cancers exosomes. Small. 2019;15:e1900735.
Luo Z, Dou J, Xie F, Lu J, Han Q, Zhou X, et al. miR-203a-3p promotes loureirin A-induced hair follicle stem cells differentiation by focusing on Smad1. Anat Rec (Hoboken). 2021;304:531–40.
Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound restore and regeneration. Nature. 2008;453:314–21.
Li M, Wang P, Li J, Zhou F, Huang S, Qi S, et al. NRP1 transduces mechanical stress inhibition by way of LATS1/YAP in hypertrophic scars. Cell Dying Discov. 2023;9:341.
Raote I, Rosendahl AH, Häkkinen HM, Vibe C, Küçükaylak I, Sawant M, et al. TANGO1 inhibitors cut back collagen secretion and restrict tissue scarring. Nat Commun. 2024;15:3302.
Liu M, López de Juan Abad B, Cheng Ok. Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug supply methods. Adv Drug Deliv Rev. 2021;173:504–19.
Rajesh R, Atallah R, Bärnthaler T. Dysregulation of metabolic pathways in pulmonary fibrosis. Pharmacol Ther. 2023;246:108436.
Wang W, Yang C, Wang XY, Zhou LY, Lao GJ, Liu D, et al. MicroRNA-129 and – 335 promote Diabetic Wound Therapeutic by inhibiting Sp1-Mediated MMP-9 expression. Diabetes. 2018;67:1627–38.
Zhang Z, Shang J, Yang Q, Dai Z, Liang Y, Lai C, et al. Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and transforming choline metabolism. J Nanobiotechnol. 2023;21:29.
Qi J, Wu Y, Guo Z, Zhu S, Xiong J, Hu F, et al. Fibroblast development issue 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy. Int J Biol Macromol. 2024;273:132896.
Bai XZ, Liu JQ, Yang LL, Fan L, He T, Su LL, et al. Identification of sirtuin 1 as a promising therapeutic goal for hypertrophic scars. Br J Pharmacol. 2016;173:1589–601.
Liang Y, Tang X, Zhang X, Cao C, Yu M, Wan M. Adipose mesenchymal stromal cell-derived exosomes carrying MiR-122-5p antagonize the Inhibitory Impact of Dihydrotestosterone on Hair follicles by focusing on the TGF-β1/SMAD3 signaling pathway. Int J Mol Sci. 2023; 24.
Guan R, Kang Z, Li L, Yan X, Gao T. PIK3CA regulates growth of diabetes retinopathy via the PI3K/Akt/mTOR pathway. PLoS ONE. 2024;19:e0295813.
Huang Y, Zhao H, Zhang Y, Tang Y, Shi X, Jiang S, et al. Enhancement of Zyxin promotes pores and skin fibrosis by regulating FAK/PI3K/AKT and TGF-β signaling pathways by way of Integrins. Int J Biol Sci. 2023;19:2394–408.
Yang BY, Zhou ZY, Liu SY, Shi MJ, Liu XJ, Cheng TM, et al. Porous Se@SiO(2) nanoparticles improve Wound Therapeutic by ROS-PI3K/Akt pathway in dermal fibroblasts and cut back scar formation. Entrance Bioeng Biotechnol. 2022;10:852482.
Dong Y, Cao X, Huang J, Hu Z, Chen C, Chen M, et al. Melatonin inhibits fibroblast cell features and hypertrophic scar formation by enhancing autophagy via the MT2 receptor-inhibited PI3K/Akt /mTOR signaling. Biochim Biophys Acta Mol Foundation Dis. 2024;1870:166887.
Rosenthal A, Kolli H, Israilevich R, Moy R. Lasers for the prevention and therapy of hypertrophic scars: a assessment of the literature. J Cosmet Laser Ther. 2020;22:115–25.
Hao M, Duan M, Yang Z, Zhou H, Li S, Xiang J, et al. Engineered stem cell exosomes for oral and maxillofacial wound therapeutic. Entrance Bioeng Biotechnol. 2022;10:1038261.
